Continuous Measurement of Activity in Patients With Muscle Pathology and in Control Subjects. ActiSLA Part.
Continuous Measurement of Activity in Patients With Muscle Pathology and in Control Subjects
Sponsor: Centre Hospitalier Régional de la Citadelle
Listed as NCT04882904, this NA trial focuses on Amyotrophic Lateral Sclerosis and remains actively recruiting participants. Sponsored by Centre Hospitalier Régional de la Citadelle, it has been updated 12 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Jan 2026 — Present [monthly]
Recruiting NA
-
Mar 2025 — Jan 2026 [monthly]
Recruiting NA
-
Sep 2024 — Mar 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
May 2024 — Jul 2024 [monthly]
Recruiting NA
▶ Show 7 earlier versions
-
Apr 2024 — May 2024 [monthly]
Recruiting NA
-
Dec 2023 — Apr 2024 [monthly]
Recruiting NA
-
Nov 2023 — Dec 2023 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting
-
Oct 2023 — Nov 2023 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2022 — Oct 2023 [monthly]
Recruiting NA
-
Oct 2021 — Jan 2022 [monthly]
Recruiting NA
-
Jun 2021 — Oct 2021 [monthly]
Recruiting NA
First recorded
Sep 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Régional de la Citadelle
- Centre Hospitalier Universitaire de Liege
- SYSNAV
For direct contact, visit the study record on ClinicalTrials.gov .